EMVision Medical Devices Ltd announced a private placement of 7,454,231 common shares at a price of AUD 2.05 per share for gross proceeds of AUD 15,281,173.55 on February 28, 2024. The transaction included participation from new investor Keysight Technologies, Inc. to acquire an 8.73% shareholding in the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 AUD | -1.98% | -5.71% | +16.81% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
151 USD | +0.14% | +2.73% | 26.36B | ||
1.98 AUD | -1.98% | -5.71% | 114M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.81% | 114M | |
+8.88% | 221B | |
+8.68% | 186B | |
+14.25% | 137B | |
+28.18% | 109B | |
+14.65% | 52.68B | |
+4.48% | 50.86B | |
+4.39% | 42.53B | |
+7.00% | 37.76B | |
+26.06% | 31.86B |
- Stock Market
- Equities
- EMV Stock
- News EMVision Medical Devices Ltd
- EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc.